Evaluation of proximal protection devices during carotid artery stenting as the first choice for embolic protection

EuroIntervention

Volumn 10, Issue 11, 2015, Pages 1362-1367

  Hornung, Marius ^a   Bertog, Stefan C ^a   Franke, Jennifer ^a   Id, Dani ^a   Grunwald, Iris ^a   Sievert, Horst ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

Author keywords

Carotid artery stenting; Flow reversal; Proximal occlusion

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ABSENCE OF COMPLICATIONS; ADULT; AGED; ARTICLE; BRAIN EMBOLISM; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBOLIC PROTECTION DEVICE; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; BRAIN ANGIOGRAPHY; CAROTID STENOSIS; CLINICAL TRIAL; DEVICES; ENDOVASCULAR SURGERY; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; RADIOGRAPHY; STENT; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; EMBOLIC PROTECTION DEVICES; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; STENTS; STROKE;

EID: 84927641864     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M07_10     Document Type: Article

References (18)

1. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
2. Stolker JM, Mahoney EM, Safley DM, Pomposelli FB Jr, Yadav JS, Cohen DJ; SAPPHIRE Investigators. Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy) trial. JACC Cardiovasc Interv. 2010;3:515-23.
3. Du Mesnil de Rochement R, Schneider S, Yan B, Lehr A, Sitzer M, Berkefeld J. Diffusion-weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenosis. AJNR Am J Neuroradiol. 2006;27:1321-5.
4. Vos JA, van den Berg JC, Ernst SM, Suttorp MJ, Overtoom TT, Mauser HW, Vogels OJ, van Heesewijk HP, Moll FL, van der Graaf Y, Mali WP, Ackerstaff RG. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology. 2005;234:493-9.
5. Chen CI, Iguchi Y, Garami Z, Malkoff MD, Smalling RW, Campbell MS, Alexandrov AV. Analysis of emboli during carotid stenting with distal protection device. Cerebrovasc Dis. 2006;21:223-8.
6. Bersin RM, Stabile E, Ansel GM, Clair DG, Cremonesi A, Hopkins LN, Nikas D, Reimers B, Sievert H, Rubino P. A metaanalysis of proximal occlusion device outcomes in carotid artery stenting. Catheter Cardiovasc Interv. 2012;80:1072-8.
7. Pieniazek P, Musialek P, Dzierwa K, Motyl R, Trystula M, Przewlocki T, Kablak-Ziembicka A, Tekieli L, Paluszek P, Moczulski Z, Sadowski J, Tracz W. Flow reversal for proximal neuroprotection during endovascular management of critical symptomatic carotid artery stenosis coexisting with ipsilateral external carotid artery occlusion. J Endovasc Ther. 2009;16:744-51.
8. Clair DG, Hopkins LN, Mehta M, Kasirajan K, Schermerhorn M, Schönholz C, Kwolek CJ, Eskandari MK, Powell RJ, Ansel GM; EMPiRE Clinical Study Investigators. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv. 2011;77:420-9.
9. Reimers B, Sievert H, Schuler GC, Tübler T, Diederich K, Schmidt A, Rubino P, Mudra H, Dudek D, Coppi G, Schofer J, Cremonesi A, Haufe M, Resta M, Klauss V, Benassi A, Di Mario C, Favero L, Scheinert D, Salemme L, Biamino G. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther. 2005;12:156-65.
10. Ansel GM, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert D, Myla S, Das T, Cremonesi A; Investigators for the ARMOUR Pivotal Trial. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv. 2010;76:1-8.
11. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Arkinson R, Cremonesi A, Fairman R, Walker G, Verta P, Popma J, Virmani R, Cohen DJ; ARCHeR Trial Collaborators. Protected carotid stenting in high-surgical-risk patients: theARCHeR results. J Vasc Surg. 2006;44:258-68.
12. Zahn R, Ischinger T, Hochadel M, Zeymer U, Schmalz W, Treese N, Eugen K, Hauptmann KE, Seggewiss H, Janicke I, Haase H, Mudra H, Senges J; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte. Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry. Eur Heart J. 2007;28:370-5.
13. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, Hopkins LN, Atkinson R, Raabe R, Barnwell S, Green R; CAPTURE Trial Collaborators. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv. 2007;70:1025-33.
14. Stingele R, Berger J, Alfke K, Eckstein HH, Fraedrich G, Allenberg J, Hartmann M, Ringleb PA, Fiehler J; SPACE investigators, Bruckmann H, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Zeumer H, Hacke W. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol. 2008;7:216-22.
15. Mas JL, Chatellier G, Beyssen B; EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke. 2004;35;e18-20.
16. Nikas D, Reith W, Schmidt A, Duda S, Mathias K, Cremonesi A, Dill H, Formgren J, Pieniazek JP, Musialek P, Hornung M, Sievert H, Reimers B. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv. 2012;80:1060-8.
17. Rabe K, Sugita J, Gödel H, Sievert H. Flow-reversal device for cerebral protection during carotid artery stenting-acute and long-term results. J Interv Cardiol. 2006;19:55-62.
18. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neuro- Interventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2011;57: 1002-44.